NCT04637867View on ClinicalTrials.gov

COVID-19 - Multicentre Study on Nosocomial Transmission of SARS-CoV-2 Virus: an Ancillary Study (NOSO-COR IMMUNO)

NACompletedINTERVENTIONAL

Enrollment

189

Participants

Timeline

Start Date

November 23, 2020

Primary Completion Date

May 12, 2021

Study Completion Date

May 12, 2021

Conditions

Infection Viral

Interventions

OTHER

Collection of blood, salivary and nasopharyngeal samples.

"Each visit M6 and M12~* Blood: 1 PAXgene tube (2.5mL) 1 EDTA tube (4mL), 1 dry tube with gel (5mL), 3 EDTA tubes (10mL each)~* Salivary sample~* Nasopharyngeal sample"

Trial Locations (2)

69003

Service épidémiologie, Hopital édouard Herriot, Lyon

hopital Edouard Herriot, Lyon

All Listed Sponsors

lead

Hospices Civils de Lyon

OTHER

NCT04637867 - COVID-19 - Multicentre Study on Nosocomial Transmission of SARS-CoV-2 Virus: an Ancillary Study (NOSO-COR IMMUNO) | Biotech Hunter | Biotech Hunter